Viewing Study NCT01351935

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2026-01-23 @ 4:31 PM
Study NCT ID: NCT01351935
Status: COMPLETED
Last Update Posted: 2019-11-08
First Post: 2011-05-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B Cell Non-Hodgkin's Lymphoma View
None Chronic Lymphocytic Leukemia View
None Waldenstrom Macroglobulinemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None non-hodgkin's lymphoma View
None lymphoma View
None leukemia View
None chronic lymphocytic leukemia View
None b-cell malignancies View
None Btk inhibitor View
None Phase 1b View
None Avila Therapeutics View
None Waldenstrom Macroglobulinemia View